 Stroke Volume
"Stroke Volume" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.
| Descriptor ID |
D013318
|
| MeSH Number(s) |
E01.370.370.380.150.700 G09.330.380.124.882
|
| Concept/Terms |
Stroke Volume- Stroke Volume
- Stroke Volumes
- Volume, Stroke
- Volumes, Stroke
Ventricular End-Systolic Volume- Ventricular End-Systolic Volume
- End-Systolic Volume, Ventricular
- End-Systolic Volumes, Ventricular
- Ventricular End Systolic Volume
- Ventricular End-Systolic Volumes
- Volume, Ventricular End-Systolic
- Volumes, Ventricular End-Systolic
Ventricular Ejection Fraction- Ventricular Ejection Fraction
- Ejection Fraction, Ventricular
- Ejection Fractions, Ventricular
- Fraction, Ventricular Ejection
- Fractions, Ventricular Ejection
- Ventricular Ejection Fractions
Ventricular End-Diastolic Volume- Ventricular End-Diastolic Volume
- End-Diastolic Volume, Ventricular
- End-Diastolic Volumes, Ventricular
- Ventricular End Diastolic Volume
- Ventricular End-Diastolic Volumes
- Volume, Ventricular End-Diastolic
- Volumes, Ventricular End-Diastolic
|
Below are MeSH descriptors whose meaning is more general than "Stroke Volume".
Below are MeSH descriptors whose meaning is more specific than "Stroke Volume".
This graph shows the total number of publications written about "Stroke Volume" by people in this website by year, and whether "Stroke Volume" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 3 | 4 | 7 | | 1998 | 0 | 3 | 3 | | 1999 | 1 | 1 | 2 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 5 | 5 | | 2003 | 2 | 5 | 7 | | 2004 | 0 | 5 | 5 | | 2005 | 0 | 3 | 3 | | 2006 | 0 | 3 | 3 | | 2007 | 0 | 7 | 7 | | 2008 | 0 | 6 | 6 | | 2009 | 1 | 4 | 5 | | 2010 | 2 | 4 | 6 | | 2011 | 3 | 5 | 8 | | 2012 | 6 | 10 | 16 | | 2013 | 8 | 6 | 14 | | 2014 | 2 | 9 | 11 | | 2015 | 5 | 14 | 19 | | 2016 | 5 | 13 | 18 | | 2017 | 7 | 20 | 27 | | 2018 | 6 | 12 | 18 | | 2019 | 11 | 16 | 27 | | 2020 | 7 | 17 | 24 | | 2021 | 9 | 20 | 29 | | 2022 | 0 | 29 | 29 | | 2023 | 0 | 37 | 37 | | 2024 | 15 | 12 | 27 | | 2025 | 10 | 18 | 28 | | 2026 | 4 | 7 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Stroke Volume" by people in Profiles.
-
Basile C, Monzo L, Farmakis D, Keramida K, Liori S, Kapelios CJ, Sverdlov AL, Grupper A, Ambrosy AP, Canonico ME. Trials and tribulations of spironolactone in heart failure with preserved ejection fraction: Insights from the SPIRIT-HF trial. Heart Fail Rev. 2026 Aug 31; 31(1).
-
Hibner BA, Lima NS, Sherman SR, Motl RW, Chirinos JA, Phillips S, Clifford PS, Reder AT, Baynard T, Fernhall B. Ventricular-vascular coupling at rest and immediately following maximal exercise in adults with and without multiple sclerosis. Physiol Rep. 2026 Aug; 14(15):e71044.
-
Hogwood AC, Smarz K, Golino M, Tysarowski M, Canada JM, Zaborska B, Dziekan-Wislawska K, Ziolo J, West JD, Jaxa-Chamiec T, Kontos E, Barron AM, Mbualungu J, Marchetta M, Lopez R, Moroni F, Arena R, Tassell BV, Abbate A. Determinants of cardiorespiratory fitness after successfully reperfused ST-elevation myocardial infarction. Curr Probl Cardiol. 2026 Oct; 51(10):103382.
-
Jacobs JA, Greene T, Vanneman ME, Kean J, Carter SJ, Shah KS, Pandey A, Derington CG, Zheutlin AR, Fang J, Stehlik J, Fonarow GC, Bress AP. Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. JAMA Cardiol. 2026 06 01; 11(6):506-514.
-
Dunlay SM, Colvin M, Cowger JA, Crespo Leiro MG, Desai AS, Greene SJ, Gustafsson F, Hall S, Ilonze OJ, Lala A, Lam CSP, Page RL, Lund LH, McDonagh TA, McIlvennan CK, Pinney SP, Truby LK, Yancy CW, Bozkurt B, Stevenson LW. Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement. JACC Heart Fail. 2026 Jun; 14(6):103101.
-
Andrade-Bucknor S, Rodriguez BPR, Ma C, Lyubarova R, Kondapalli L. Imaging in Cardio-Oncology: Role of Novel Echo Parameters in Breast Cancer and Gynecologic Malignancies. Curr Cardiol Rep. 2026 Apr 23; 28(1).
-
Martins EB, Madrini V, Ramos Souza PV, Tavares CAM, Albuquerque MT, Santo KE, Harrington JA, Canonico ME, El Rafei A, Bonaca MP, Guimaraes PO. ANSWER-HF: sacubitril-valsartan reduces NT-proBNP in heart failure due to Chagas cardiomyopathy despite no reverse remodeling. Heart Fail Rev. 2026 03 23; 31(1).
-
Leahy MG, Howden EJ, Lawley JS, Cornwell WK, MacNamara JP, Levine BD, Sarma S. The effect of sex on ventricular filling pressure during graded exercise in healthy young adults. J Appl Physiol (1985). 2026 04 01; 140(4):1099-1107.
-
Butler J, Fioretti F, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Teixeira PP, Ezekowitz JA, Gates D, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Zannad F. Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial. Eur Heart J. 2026 Feb 11; 47(6):683-697.
-
Harrington J, Pandey A. Heart failure with preserved ejection fraction: a systemic condition of comorbidities. Heart Fail Rev. 2026 02 03; 31(1):22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|